Analysis of United States' Catheters Market, 2019-2025: Cardiovascular, Urological, Intravenous, Specialty, and Neurovascular Catheters - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "US Catheters Market 2019-2025" report has been added to ResearchAndMarkets.com's offering.

US catheters market is expected to grow at a CAGR of nearly 8.2% during the forecast period.

The major factors encouraging the growth of the market in the region include The increasing number of multi-specialty hospitals and the increasing number of urologic clinics coupled with the increasing number of urologists is estimated to drive the demand for urinary flow meters in hospitals and clinics. For instance, as per the American Urological Association, in the US, the national urologist-to-population ratio increased to 3.89 per 100,000 population in 2017, up from 3.85 in 2016. This rising number of urologists is expected to increase the possibilities for opening of new urologic clinics, which in turn, will drive the adoption of urinary catheters which is a tube inserted in the body to drain the bladder.

Rising aging population leads to the rise in the incidences of urinary disorders in the country. As per the Population Reference Bureau (PRB), the number of Americans ages 65 and older is projected to nearly double from 52 million in 2018 to 95 million by 2060, and the 65-and-older age group's share of the total population will rise from 16% to 23%. With the growing ageing population, the prevalence of urinary conditions, especially in the elderly, is expected to increase. For instance, lower urinary tract dysfunction, including benign prostatic hyperplasia and urinary incontinence is prevalent in aged persons. Therefore, a significant rise in the ageing population is another factor encouraging the demand for urinary catheters across hospitals and clinics.

The major companies operating in the region include Abbott Laboratories, Inc., Boston Scientific Corp., and Johnson & Johnson Services, Inc. To survive in the market, these players are adopting crucial strategies, such as mergers and acquisitions, product launches, and partnerships and collaborations. This enables the company to increase its competitiveness and attract significant share in the market. For instance, in May 2018, Abbott Laboratories, Inc. expands portfolio of cardiac arrhythmias with FDA clearance for the Advisor HD Grid Mapping Catheter, Sensor Enabled. The purpose to develop this product was to offer innovative solutions to the physicians to accurately and quickly map complex cardiac arrhythmias among patients.

The report covers:

• A comprehensive research methodology of the US catheters market.
• A detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the US catheters market.
• Insights about market determinants which are stimulating the US catheters market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.

Key Topics Covered

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segment

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

2.3. Rules & Regulations

3. Competitive Landscape

3.1. Company Share Analysis

3.2. Key Strategy Analysis

3.3. Key Company Analysis

3.3.1. Overview

3.3.2. Financial Analysis

3.3.3. SWOT Analysis

3.3.4. Recent Developments

4. Market Determinants

4.1. Motivators

4.2. Restraints

4.3. Opportunities

5. Market Segmentation

5.1. US Catheters Market by Product Type

5.1.1. Cardiovascular Catheters

5.1.2. Urological Catheters

5.1.3. Intravenous Catheters

5.1.4. Specialty Catheters

5.1.5. Neurovascular Catheters

6. Company Profiles

6.1. Abbott Laboratories, Inc.

6.2. Becton Dickinson and Co.

6.3. Boston Scientific Corp.

6.4. Edwards Lifesciences Corp.

6.5. Integra Lifesciences Corp.

6.6. Johnson & Johnson Services, Inc.

6.7. Medtronic plc

6.8. Stryker Corp.

6.9. Teleflex, Inc.

6.10. Terumo Medical Corp.

For more information about this report visit https://www.researchandmarkets.com/r/saiv8o